|1.||Lee, Kang Choon: 1 article (09/2015)|
|2.||Lee, Eun Seong: 1 article (09/2015)|
|3.||Byeon, Hyeong Jun: 1 article (09/2015)|
|4.||Choi, Ji Su: 1 article (09/2015)|
|5.||Choi, Han-Gon: 1 article (09/2015)|
|6.||Youn, Yu Seok: 1 article (09/2015)|
|7.||Lee, Seunghyun: 1 article (09/2015)|
|8.||Kim, Insoo: 1 article (09/2015)|
|9.||Shin, Beom Soo: 1 article (09/2015)|
|10.||Fang, Xiaoling: 1 article (01/2015)|
09/28/2015 - "Specifically, tumors (volume: 278.8mm(3)) in Mia Paca-2 cell-xenografted BALB/c nu/nu mice treated with the TRAIL-loaded HSA-PEG hydrogel were markedly smaller than mice treated with the hydrogel prepared via an amine-N-hydroxysuccinimide reaction or non-treated mice (1275.5mm(3) and 1816.5mm(3), respectively). "
01/01/2015 - "c(RGDyK) that can bind to the integrin protein richly expressed at the site of tumor vascular endothelial cells and tumor cells with high affinity and specificity was conjugated to the N-hydroxysuccinimide-activated PEO terminus of the Pluronic F127 block copolymer. "
01/01/2014 - "The surface of NPs was further decorated with solubilizing agent polyethylene glycol (PEG) and tumor endothelial marker 1 (TEM1)/endosialin-targeting antibody (Ab) through carbodiimide/N-hydroxysuccinimide chemistry. "
07/23/2012 - "To capture tumor cells actively, FA molecules were attached onto the surface of the Ag@Au@PFR particles in the presence of 1-ethyl-3-(3-dimethly aminopropyl) carbodiimide (EDAC) and N-hydroxysuccinimide (NHS). "
07/01/2001 - "(AIL), a parasitic plant, by affinity chromatography on an N-hydroxysuccinimide-activated Sepharose High Performance column bound with F3, a monoclonal antibody that neutralizes the cytokine-inducing and anti-tumor effect of AIL. "
|2.||Breast Neoplasms (Breast Cancer)
11/01/2010 - "An N-hydroxysuccinimide group (NHS) on the OA-PEG-80 was used to conjugate the amine functional group on antibodies for active targeting in the human MCF-7 breast cancer cell line. "
10/01/2009 - "The objective of this study was to prepare and characterize rapamycin loaded polymeric poly(lactide-co-glycolide) (PLGA) nanoparticles (NP) that were surface conjugated with antibodies to epidermal growth factor receptor (EGFR), highly expressed on breast cancer cells, using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS) mediated cross linking agents. "
05/21/2011 - "In this study we used a tumor cell-specific peptide, chlorotoxin (CTX), to mediate glioma cell adhesion on arrays of gold microelectrodes and investigated the effects of three surface modification schemes for conjugation of CTX to the microelectrodes on single cell patterning, which include physical adsorption, covalent bonding mediated by N-hydroxysuccinimide (NHS), and covalent bonding via crosslinking succinimidyl iodoacetate and Traut's (SIA-Traut) reagents. "
|4.||Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
07/01/2008 - "A direct immunoassay assessment of streptavidin- and N-hydroxysuccinimide-modified biochips in validation of serological TNFalpha responses in hemophagocytic lymphohistiocytosis."
07/01/2008 - "The authors report 2 biochip platforms on gold manufactured by either nanoscale biotinylated self-assembled architectures to streptavidin surface or proteins containing free NH(2) groups to N-hydroxysuccinimide (NHS)-activated surfaces and investigated the potential application of tumor necrosis factor-alpha (TNFalpha) serodiagnosis of hemophagocytic lymphohistiocytosis (HLH). "
|4.||Epidermal Growth Factor Receptor (EGF Receptor)
|7.||Indicators and Reagents (Reagents)
|9.||polylactic acid-polyglycolic acid copolymer (PLGA)
|10.||Polyethylene Glycols (Polyethylene Glycol)